Real-World Data for Luspatercept in Lower-Risk MDS

Valeria Santini, MD, reviews data from real-world outcomes in clinical trials investigating luspatercept in patients with lower-risk MDS.

Related Keywords

Valeria Santini , ,Future Treatment Strategies ,World Data ,Lower Risk Mds ,Lower Risk Myelodysplastic Syndrome ,Myelodysplastic Syndrome ,Mds ,Luspatercept ,